Drugs / n-3 PUFAs
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT01223703 Comparator | Nov 2007 → Jun 2009 | dilated cardiomyopathy, heart failure | University of Brescia | Completed | No outcome recorded |
| Phase 3 | NCT01198275 Comparator | Jan 2006 → May 2008 | atrial fibrillation | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | n-3 PUFAs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01198275 ↗ |
| Modality | Other / unclassified | “n-3 polyunsaturated fatty acids (n-3 PUFAs) exert antiarrhythmic effects and reduce sudden cardiac death.” PMID 21844082 ↗ Aug 2011 |